You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -205.7% | -31.3% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -1.4 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 2.6 | 1.8 |
Price / Book value | 2.9 |
Latest | Forecast | |
---|---|---|
Revenue | -36.0% | -19.5% |
PBT | 0.0% | n/a |
EPS | 0.0% | 142.2% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | 64.06 | -20.89 | -22.10p | -29.2 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 87.73 | -6.57 | -7.81p | -131.9 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 142.80 | 19.88 | 22.77p | 54.0 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 139.99 | -45.98 | -41.29p | -10.7 | 0.0 | n/a | n/a | 0.0% |
2023-12-31 | 89.54 | -188.53 | -163.11p | -1.3 | 0.0 | n/a | n/a | 0.0% |
Oxford Biomedica confident as it moves away from vaccine era Sharecast News | 08:09 |
---|---|
Oxford Biomedica shares rise on post-acquisition guidance Sharecast News | 05 Mar |
Director dealings: TUI, Oxford Biomedica board members linked to buys Sharecast News | 27 Sep |
Prelim Results for Y/E 2023 - REPLACEMENT | 29-Apr-24 10:22 |
---|---|
Preliminary results for the year ended 31 Dec 2023 | 29-Apr-24 07:01 |
Total Voting Rights | 02-Apr-24 23:59 |
Update on CDMO Services | 20-Mar-24 07:00 |
Board Changes | 11-Mar-24 15:25 |